Measuring secondary traumatic stress in therapists: A systematic review.

Psychol TraumaJan 15, 2026 (epub)
Clinical ResearchPsychiatry

Aleksandra Paksina, Susannah Jenner, Aimee McKinnon

✦ AI-curated · Sources linked

In 30 seconds

This systematic review examined how secondary traumatic stress (STS) is measured in therapy-offering mental health clinicians. Searches of five databases identified 49 eligible quantitative, peer-reviewed studies published in English through December 2024. The review found seven instruments; the Professional Quality of Life Scale and Secondary Traumatic Stress Scale were most commonly used and assess STS from different perspectives. Reliability generalization indicated acceptable internal consistency for the former and excellent internal consistency for the latter. The authors concluded that no single measure captures the full domain of STS and that measure selection should reflect the symptoms of interest.

Key findings

  • The review included 49 studies and identified seven instruments used to measure STS in mental health clinicians.
  • The Professional Quality of Life Scale and Secondary Traumatic Stress Scale were the most frequently used measures.
  • Reliability generalization suggested acceptable internal consistency for the Professional Quality of Life Scale and excellent internal consistency for the Secondary Traumatic Stress Scale.
  • No single instrument was found to capture the entire domain of STS.

Why it matters

Measurement differences can make findings across studies difficult to compare and limit conclusions about STS in clinicians. Recognising that commonly used instruments assess STS from different perspectives helps interpret reported scores and supports more deliberate selection of outcomes in research and clinical assessment.

What to keep in mind

The review describes methodological inconsistencies in the underlying literature, including variation in measurement and populations studied; its conclusions are limited by the available studies and instruments.

Source

Published in Psychol Trauma. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.